Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion)
Open Access
- 8 February 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Neurology
- Vol. 12 (1), 3
- https://doi.org/10.1186/1471-2377-12-3
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Retinal microvascular abnormalities and cognitive dysfunction: a systematic reviewBritish Journal of Ophthalmology, 2008
- Low dose aspirin and cognitive function in the women's health study cognitive cohortBMJ, 2007
- Cognitive Functioning in Healthy Older Adults Aged 64–81: A Cohort Study into the Effects of Age, Sex, and EducationAging, Neuropsychology, and Cognition, 2007
- National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization StandardsStroke, 2006
- Retinal Microvascular Abnormalities and MRI-Defined Subclinical Cerebral InfarctionStroke, 2006
- Progress of leukoaraiosis is inhibited by correction of platelet hyper-aggregabilityInternational Psychogeriatrics, 2005
- Retinal Microvascular Abnormalities and Cognitive Impairment in Middle-Aged PersonsStroke, 2002
- Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities StudyThe Lancet, 2001
- Lacunar infarcts and white matter attenuation. Ophthalmologic and microcirculatory aspects of the pathophysiology.Stroke, 1993